ECG: Record $5.5B backlog and higher FY2026 guidance cap a quarter of strong growth

What happened

ECG reported third-quarter revenue growth of 40.3% and EBITDA growth of 57.5%, with its EBITDA margin rising to 10.1%. The company also reported a record $5.5B backlog and raised its FY2026 revenue and EBITDA guidance, citing E&M demand and acquisition contributions.

Confirmed

Global impact / market context

The larger backlog represents work awaiting completion and may support future revenue if projects proceed as planned. Stronger guidance suggests management expects demand and acquired businesses to contribute to growth, while the higher EBITDA margin indicates more operating profit relative to revenue.

Analyst inference

The reported growth combines demand in E&M with acquisition contributions, so investors cannot tell from this summary how much came from existing operations versus acquired businesses. The backlog and raised guidance offer forward-looking signals, but neither guarantees future results.

Analyst inference

What to watch

1. Future results should show whether revenue growth continues and whether the 10.1% EBITDA margin is sustained as the company completes work and integrates acquisitions. Analyst inference
2. The next guidance update could clarify the expected revenue and EBITDA contribution from E&M demand and acquisitions, as well as any changes to FY2026 expectations. Analyst inference
3. Watch for updates on the $5.5B backlog, including whether projects are converted into reported revenue and whether new demand replaces completed work. Analyst inference

Evidence

• Original source link unavailable